- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/475 - Growth factorsGrowth regulators
Patent holdings for IPC class C07K 14/475
Total number of patents in this class: 1686
10-year publication summary
|
113
|
104
|
110
|
138
|
118
|
123
|
102
|
102
|
90
|
71
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 356 |
40 |
| The Board of Trustees of the Leland Stanford Junior University | 6526 |
25 |
| The General Hospital Corporation | 4797 |
25 |
| The Regents of the University of California | 20268 |
24 |
| Amgen Inc. | 4163 |
22 |
| Modernatx, Inc. | 1296 |
20 |
| Zensun (Shanghai) Science & Technology, Co., Ltd. | 57 |
20 |
| The Brigham and Women's Hospital, Inc. | 2221 |
19 |
| NGM Biopharmaceuticals, Inc. | 175 |
17 |
| Genentech, Inc. | 4008 |
16 |
| Children's Medical Center Corporation | 1909 |
16 |
| Regeneron Pharmaceuticals, Inc. | 4426 |
15 |
| Centre National de La Recherche Scientifique | 10666 |
13 |
| President and Fellows of Harvard College | 6030 |
13 |
| Scholar Rock, Inc. | 124 |
12 |
| The Johns Hopkins University | 5752 |
11 |
| Silver Creek Pharmaceuticals, Inc. | 29 |
11 |
| The Trustees of the University of Pennsylvania | 4376 |
10 |
| Northwestern University | 3450 |
10 |
| Eli Lilly and Company | 3911 |
10 |
| Other owners | 1337 |